INS and neoplasm: Generally, metformin induces its anticancer effect via two main mechanisms: [1] direct mechanism resulting from its suppression of adenosine triphosphate (ATP) production due to the inhibition of mitochondrial complex I and [2] indirect mechanism involving “endocrine-type effects” related to its insulin-lowering activity which may suppress tumor development in hyperinsulinemic patients.